Checkpoint Therapeutics, Inc. (CZTA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:03AM CEST
| Previous close | 1.4820 |
| Open | 1.4480 |
| Bid | 1.4880 x N/A |
| Ask | 1.5180 x N/A |
| Day's range | 1.4480 - 1.4480 |
| 52-week range | 1.2860 - 3.0380 |
| Volume | |
| Avg. volume | 152 |
| Market cap | 51.345M |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Checkpoint Therapeutics Full Year 2023 Earnings: Misses Expectations
Checkpoint Therapeutics ( NASDAQ:CKPT ) Full Year 2023 Results Key Financial Results Net loss: US$51.8m (loss narrowed...
- Simply Wall St.
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Profit Outlook
We feel now is a pretty good time to analyse Checkpoint Therapeutics, Inc.'s ( NASDAQ:CKPT ) business as it appears the...
- Reuters
UPDATE 1-US FDA declines to approve Checkpoint Therapeutics' skin cancer therapy
Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration declined to approve its experimental therapy to treat a type of advanced skin cancer, citing issues related to a third-party contract manufacturer. Checkpoint said the FDA did not state any concerns about the data or safety on the drug in its so-called complete response letter.
© 2024 Yahoo. All rights reserved.